Furthermore, analyses of clinical baseline data demonstrated obvious differences in BMI, Ferriman–Gallwey score, FINS, T, LH/FSH, TNF-α, and IL-6 levels among the PCOS-obese group and PCOS-nonobese group (all P < 0.05). The gene discussed is BRD2; the disease is polycystic ovary syndrome.